Showing results (31-40 of 182) with videos related to
Sort By:
Pageof 19
Multiple Sclerosis and Related Disorders|March 5, 2025
Efficacy of pharmacologic treatments for fatigue in multiple sclerosis: A systematic review and meta-analysisKarlo Toljan, Albert Aboseif, Moein AminExperimental and Molecular Pathology|March 10, 2015
Current perspectives of mi-RNA in oesophageal adenocarcinoma: Roles in predicting carcinogenesis, progression and values in clinical managementMoein Amin, Alfred King-yin LamNeurology. Clinical Practice|March 20, 2020
Primary CNS lymphoma initially diagnosed as vasculitisLauren Feldman, Yuebing Li, Daniel OntanedaAnnals of Indian Academy of Neurology|February 26, 2010
Management of acute exacerbations in multiple sclerosisDaniel Ontaneda, Alex D Rae-GrantExpert Review of Neurotherapeutics|May 2, 2023
The benefits and risks of escalation versus early highly effective treatment in patients with multiple sclerosisAnnalisa Morgan, Emma Tallantyre, Daniel OntanedaMultiple Sclerosis and Related Disorders|September 16, 2014
Risk stratification and mitigation multiple sclerosisDaniel Ontaneda, Samuel Cohn, RobertJ FoxFrontiers in Immunology|July 14, 2026
Multiple sclerosis as an asynchronous neuroinflammatory systemEmanuele D'Amico, Aurora Zanghì, Daniel OntanedaPlos One|September 1, 2021
Automatic segmentation of gadolinium-enhancing lesions in multiple sclerosis using deep learning from clinical MRISibaji Gaj, Daniel Ontaneda, Kunio NakamuraMultiple Sclerosis (Houndmills, Basingstoke, England)|March 22, 2021
Juxtacortical susceptibility changes in progressive multifocal leukoencephalopathy at the gray-white matter junction correlates with iron-enriched macrophagesKedar R Mahajan, Moein Amin, Matthew Poturalski, et al.Annual Review of Medicine|September 6, 2011
Multiple sclerosis: new insights in pathogenesis and novel therapeuticsDaniel Ontaneda, Megan Hyland, Jeffrey A CohenPageof 19